Renal transplantationFk 506–induced fulminant leukoencephalopathy after kidney transplantation: case report
Section snippets
Case report
An 18-year-old male with chronic renal failure underwent an uncomplicated renal transplantation from his mother using an immunosuppression protocol of mycophenolate mofetil (2 × 750 mg/d), tacrolimus (2 × 3 mg/day), and prednisolone (2 × 250 mg/d).
The patient had no neurologic complaints during the early postoperative period; however, 2 months later he developed a mild tremor and cramps in both hands. His whole-blood tacrolimus level was 14.5 ng/mL (target range 5 to 20 ng/mL). The cranial
Discussion
FK 506–induced neurotoxicity may occur early or late namely, less than 2 weeks or more than 2 months after the start of treatment, respectively. The reported incidence varies from 5% to 30%.2 The precise mechanism is unknown. Although tacrolimus may produce direct neurotoxic effects, resulting in axonal swelling, increased water content and edema,10 a vascular mechanism has also been postulated. Administration of the drug has been associated with vacuolization of the smooth muscle cells of
References (15)
- et al.
Ann Thorac Surg
(1997) - et al.
Ann Surg
(1990) - et al.
Transplant Proc
(1991) Ann Pharmacother
(1994)- et al.
Transplantation
(1994) - et al.
Br J Clin Pharmacol
(1999) - et al.
Transplant Proc
(1991)
Cited by (6)
Role of the tacrolimus in posterior reversible encephalopathy syndrome
2015, Nobel MedicusLate fulminant posterior reversible encephalopathy syndrome after liver transplant
2009, Experimental and Clinical Transplantation